| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
12-08-2009, 07:04 PM
|
#1 | ||
|
|||
|
In Remembrance
|
Nobody’s talking about this. I can’t hear a word they’re saying..only..in the echos of my mind.
Starting now, through 2011, there is going to be a “global change” in the distribution and availability of brand name Sinemet and CR. Here is the reason highlighted in the letter to British neurologists as the UK is the lucky country to first have their med sold out from under them at a higher price to other countries, and told to use an alternative. http://www.theabn.org/Newsdetails.aspx?news=426 s temporary shortage is related to a change in the source of supply for the drug and the necessary timelines needed to obtain regulatory approvals for this supply change. It is important to note that this situation is not due to product quality or safety issues, nor is it due to delays on the part of individual regulatory agencies that approve this supply change. To address the expected shortfall, Merck & Co., Inc. (Merck), our parent company, and MSD are taking action to manage available supply of these products through a process that primarily takes into account patient needs, as well as availability of alternative treatments (which exist in most markets), and contractual obligations. In accordance with our analysis, some markets will get their full needs met, many will experience a significant shortfall in their supply, and many will not get any supply of these products. We know that it can be difficult for physicians to find the optimum treatment regimen for Parkinson's patients and we know that it can be difficult to change therapies. We apologize in advance as we know that some physicians and patients may experience temporary challenges if therapies need to be changed. Many countries are being asked to take reduced allocations so that Merck and MSD can supply product to patients in countries that have no or limited alternative treatment options. We want to thank you for your understanding, assistance, cooperation and patience as we do our best to put patients first from a global perspective. We want to assure you that we are working hard to return to the level of customer service that you expect from MSD. They are ‘exporting ‘ to countries that need it “ more.” Great market boost for generics [hope they have enough of them don’t you?] and look for recommendations of stalevo. Oh boy! 23:00 GMT, Saturday, 22 August 2009 00:00 UK Chemist warning on drug shortages Pharmacists have been having stock problems for months Pharmacists are warning that patients are suffering because of a shortage of some medicines. An attractive export market and quotas set by drug manufacturers are being blamed for ongoing stock problems with more than 50 branded medicines. A third of pharmacies polled by Chemist and Druggist magazine said shortages were now directly affecting patients, with one patient ending up in hospital. The government said it was "monitoring the situation closely". It can't be right for patients to be suffering like this Roger Odd Patient's Association More than 150 pharmacies responded to the survey, almost 90% of whom said they were "very concerned" about problems they were having getting hold of some medicines. And 32% said they had already seen patients suffer because of stock shortages. Some reported patients being extremely distressed when they were not able to obtain their prescribed drugs. Others had seen a patient's condition deteriorate with one even being admitted to hospital. The vast majority said they had had to ask a GP to rewrite a prescription for a different drug when they could not get hold of stock. One pharmacist reported a patient suffering panic attacks waiting for an antidepressant called Cipralex and another had been extremely distressed while waiting for Femara, which is a drug used to treat breast cancer. Another said a patient's blood pressure had gone up while waiting for their medicine and that a shortage of Plavix, a clot-busting drug, led to a patient being admitted to hospital. Anxiety Jeremy Holmes, chief executive of the Royal Pharmaceutical Society of Great Britain, said it was concerned about the stock problems. "This problem has been exacerbated recently by parallel exporting, where a product is bought in the UK in order to sell onto another country at a higher price." He added: "The current supply chain relies on medicines being available within 24 to 48 hours. "When this doesn't happen it causes stress and anxiety to those affected - and it is the patients who suffer most." A spokesman for the Department of Health said it was vitally important that people get the medicines they need and were aware of the issue. "We are working with pharmacists, pharmaceutical companies and wholesalers to better understand these concerns, and will continue to monitor the situation closely in order to address these." Conservative and Liberal Democrat MPs condemned the situation as unacceptable. Howard Stoate MP, chair of the All Party Pharmacy Group, said the group was "extremely concerned" that patients were unable to access medicines. Roger Odd, a trustee of the Patients' Association, said: "There are 50 or more medicines that have been out of stock - it's unbelievable. "It can't be right for patients to be suffering like this." David Fisher, of the Association of the British Pharmaceutical Industry, said patients were being put at risk because medicines intended for UK patients are being diverted for export. "Industry very much shares patient concerns and has been working with Department of Health and pharmacy bodies on solutions." http://news.bbc.co.uk/1/hi/8214713.stm this link indicates that the letter is titles 'letter to NGO's" http://www.p-cns.com/ An attractive export market and quotas set by drug manufacturers are being blamed for ongoing stock problems with more than 50 branded medicines. A third of pharmacies polled by Chemist and Druggist magazine said shortages were now directly affecting patients, with one patient ending up in hospital. The government said it was "monitoring the situation closely". http://news.bbc.co.uk/2/hi/8214713.stm anonymous pwp: www.silobreaker.com/sinemet-supply-shortage-5_2262786855424491529 http://www.psnc.org.uk/news.php/637/...upply_shortage My prescription was refused by gp computer as 'drug overuse' because i requested it 2 days earlier than usual. Took 6 days to resolve. Picked up a months supply from pharmacist today. She showed me article in pharmacists magazine about sinemet shortage. Also thought that they are trying to push patients onto stalevo which is a more expensive drug.
__________________
paula "Time is not neutral for those who have pd or for those who will get it." Last edited by paula_w; 12-09-2009 at 09:00 AM. |
||
|
 Reply With Quote
|
|
12-08-2009, 10:42 PM
|
#2 | |||
|
||||
|
Senior Member
|
Aha! I knew they would find a way to coerce Parkinson's doctors and pharmacists and patients to use generic drugs. Any pharmacy worth its salt will tell you that all generics are NOT equal.
I don't like the smell of this. Oh, that's right1 Most PWP's can't smell! LOL Peg 
|
|||
|
|
Reply With Quote
|
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| Sinemet vs Sinemet CR: Your Experience? | Parkinson's Disease | |||
| We’ve got Sinemet so we are ok | Parkinson's Disease | |||
| Sinemet | Peripheral Neuropathy | |||
| Sinemet How much? | Parkinson's Disease | |||
| ms and sinemet | Multiple Sclerosis | |||
Sinemet shortage
Linear Mode
